Latest News

Wednesday, July 26, 2017 | Skin Cancer, Research and Publications

Study IDs Risk Factors for Melanoma in Kidney Transplant Recipients

Kidney transplant patients appear to be at a greater risk of developing melanoma than the general population and risk factors include being older, male and white, findings that corroborate results dem…

Read the full story

Wednesday, July 26, 2017 | Skin Cancer, Skin Care, Product Launches and Updates, Research and Publications

Innovation in Action: Meet the DNA Sunscreen that Gets Better the Longer You Wear It

Researchers at Binghamton University, State University of New York have developed a coating made out of DNA that gets better at protecting skin from Ultraviolet light the more you expose it to the sun…

Read the full story

Wednesday, July 26, 2017 | Skin Cancer, Research and Publications

Simulation Techniques Help Medical Students Empathize with Melanoma Patients

Simulation techniques can allow doctors to experience what it feels like to be a melanoma patient. The study, which is led by Queen’s University in Belfast collaboration with researchers from…

Read the full story

Tuesday, July 25, 2017 | Acquisitions and Mergers, Skin Care, Allergan , SkinMedica, Suneva

Histogen’s Growth Factor Technology Now Part of Allergan's Skin Care Line

Histogen’s growth factor technology will be marketed as part of Allergan's skin care line within its recently acquired Regenica® Advanced Rejuvenation System. The Regenica line is bas…

Read the full story

Monday, July 24, 2017 | Lasers & Light Devices, American Society for Laser Medicine and Surgery

Early Use of CO2 Lasers on Surgical Scars Bests Silicone Gel Treatment

Early treatment of surgical scars with a super-pulsed fractional C02 laser shows promise, new research suggests. The study, which appears in Lasers in Surgery and Medicine (LSM), found that laser t…

Read the full story

Monday, July 24, 2017 | FDA Approval/Clearance, Skin Cancer, Product Launches and Updates, Bristol-Myers Squibb

FDA Expands Approval of Yervoy to Include Pediatric Patients 12 Years and Older with Unresectable or Metastatic Melanoma

The FDA has expanded the indication for Bristol-Myers Squibb's Yervoy (ipilimumab) injection for intravenous use to now include the treatment of unresectable or metastatic melanoma in pediatr…

Read the full story

Thursday, July 20, 2017 | Psoriasis, Leo

LEO Pharma Receives EU Marketing Authorization for Kyntheum to Treat Plaque Psoriasis

The European Commission has granted marketing authorisation for LEO Pharma's Kyntheum (brodalumab), a new biologic for the treatment of moderate-to-severe plaque psoriasis in adults within the Eur…

Read the full story

Wednesday, July 19, 2017 | Skin Cancer

DermTech Secures Billing Codes for its Proprietary Melanoma Test

The American Medical Association (AMA) has granted DermTech, Inc. Category 1, Tier 2 Molecular Pathology procedure codes related to its proprietary test for the detection of melanoma related gene expr…

Read the full story

Wednesday, July 19, 2017 | Personnel/Company News, Allergan

Joseph H. Boccuzi Appointed to Allergan plc Board of Directors

Allergan plc has named Joseph H. Boccuzi to its Board of Directors, effective immediately.  Mr. Boccuzi recently retired as a Partner in the Global Life Sciences, Board and Chief Executive Office…

Read the full story

Tuesday, July 18, 2017 | Acquisitions and Mergers, Skin Care, Obagi, Valeant NJ

Valeant to Sell Obagi Medical Products Business for $190 M

Valeant Pharmaceuticals International, Inc. has entered into an agreement to sell its Obagi Medical Products business for $190 million in cash to Haitong International Zhonghua Finance Acqui…

Read the full story

Monday, July 17, 2017 | Phase 3/4 Trials

Paratek: Phase 3 Study of Oral-Only Dosing of Omadacycline Met FDA and EMA Efficacy Endpoints in Acute Bacterial Skin Infections

Paratek Pharmaceuticals, Inc. shared positive top-line results from a pivotal Phase 3 study comparing its once-daily, oral investigational antibiotic, omadacycline, to twice-daily oral linezolid in th…

Read the full story

Monday, July 17, 2017 | Business of Medicine, Galderma

Galderma CareConnect Patient Savings Card Program Passes Milestone

The Galderma CareConnect patient savings program has surpassed the mark of 1,000,000 prescriptions filled through its patient access program. Committed to keeping accessibility remarkably simple and s…

Read the full story

Monday, July 17, 2017 | Corporate Lawsuits, Acne, Galderma

Patent Challenge Filed for Generic Version Of Soolantra Cream

Perrigo Company plc's subsidiary has filed a Paragraph IV Abbreviated New Drug Application with the FDA for a generic version of Soolantra® (ivermectin) cream, 1%. Following notification fr…

Read the full story

Monday, July 17, 2017 | Acquisitions and Mergers, Business of Medicine, Personnel/Company News, Syneron

Syneron Candela Completes Transaction with Funds Advised by Apax Partners; Becomes a Private Company

Syneron Medical Ltd. announced the successful completion of its acquisition by an affiliate of funds advised by Apax Partners for $11.00 per share in cash in a transaction valued at approximately $400…

Read the full story

Friday, July 14, 2017 | Skin Cancer, Research and Publications

Tomatoes May Slash Skin Cancer Risk

Daily tomato consumption may cut skin cancer risk in half, according to a new study in mice. The Ohio State University researchers report their findings online in the journal Scientific Reports. …

Read the full story
Load More
 Stock Price  Change 
 AbbVie $72.59  0.10% 
 Allergan $256.15  0.56% 
 Amgen $175.89  -2.76% 
 Bayer AG $130.57  0.43% 
 Celgene $137.75  0.96% 
 Cutera $26.70  -1.66% 
 Cynosure $0.00  0.00% 
 GlaxoSmithKline $40.85  -2.65% 
 Johnson and Johnson $130.95  -0.71% 
 Lily $81.84  -0.44% 
 Nestle $86.35  -0.22% 
 Novartis $84.85  0.77% 
 Pfizer $32.89  -0.63% 
 Proctor and Gamble $89.30  0.18% 
 Taro $115.34  0.16% 
 Unilever $58.30  0.92% 
 Valeant $17.77  0.34%